Furthermore, our investigation into the impact of PB1‐p62 on tumor progression confirmed its dose‐dependent inhibitory effect on tumor growth (Figure S6C–E and Tables S4 and S5, Supporting Information). This evidence concerns the gene SQSTM1 and neoplasm.